title: Localized lipoatrophy after glatiramer acetate injection in patients with remitting-relapsing multiple sclerosis.
authors.forename: F
authors.initials: F
authors.lastname: Drago
authors.forename: C
authors.initials: C
authors.lastname: Brusati
authors.forename: G
authors.initials: G
authors.lastname: Mancardi
authors.forename: A
authors.initials: A
authors.lastname: Murialdo
authors.forename: A
authors.initials: A
authors.lastname: Rebora
mesh_terms: D000328:Adult; D005260:Female; D000068717:Glatiramer Acetate; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008060:Lipodystrophy / Q000139:chemically induced*; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy*; D010455:Peptides / Q000009:adverse effects*; D012008:Recurrence
chemical_list: D007166:Immunosuppressive Agents; D010455:Peptides; D000068717:Glatiramer Acetate